Primary tumors were ER positive in 192 (73.6%) and HER2 positive in 51 patients (19.5%) while the same was true for metastatic tumor biopsies in 182 (69.7%), and 52 patients (19.9%), respectively. The gene discussed is ERBB2; the disease is metastatic neoplasm.